Younong Xu

Younong Xu Work

X

Chief Technology Officer

@ XXX Biopharm Ltd.

C

Executive Director

@ Clover Biopharmaceuticals

G

Associate Director of scientific program

@ Global Health Drug Discovery Institute

Younong Xu Education

1997 - 2001 PhD in Viral Immunology

Kyoto University
1981 - 1985 BS in Molecular Biology and Virology

Wuhan University

Younong Xu Skills

ImmunologyVirologyMolecular BiologyOncologyBiotechnologyCancer Vaccines (colon cancer, breast cancer).Cnacer vaccines (head and neck cancer, and prostate cancer).Vaccines against viruses (HIV and Influenza, including H1N1).Monoclonal antibody for HBV, Influenza, CMV, bladder cancer.HPLC, CD and Biacore.Writing NIH grants for PI, SOPs, documents for regulatory submissions.Animal models (mouse or monkey models or human samples).Clinical Development, Clinical Research and Clinical Trials.Infectious Diseases (HIV/AIDS, Influenza, HBV, CMV)Development of analytical methods for assay validation and transfer.Cell-based assays (Ab neutralization assay, MAGI assay, Pseudovirus assay).Skilled in flow cytometry, drug sensitivity, and drug toxicity assay.ELISpot, Genescan, CTL epitope mapping, CTL 51Cr release assay.MHC-restriction typing, all stage of CTL clone generation.All stages of monoclonal antibody generation.Detection technologies (fluorescence, luminescence, ECL).Construction of plasmid, site-directed mutagenesis, Western blot.Proficient with MEGA3.1, LANL, NCBI, PAUP*, McClade, Clustalw, Sequencher.Excellent communication skills in English, Japanese and Chinese.Strong organizational skills in managing and leading collaborative studies.Drug DiscoveryInfectious DiseasesCell BiologyLife SciencesVaccinesCancerCancer Vaccines Colon CancerWritingMonoclonal Antibody for HbvPrimatesClinical TrialsPseudovirus AssayDocuments for Regulatory SubmissionsFlowjoPolSivAnimal ModelsLoopProstateStrainDrug SensitivityDrug Toxicity AssayManuscriptConsiderationClinical ResearchHpvAdvancementJenkinsSeattleEvolutionCnacer Vaccines Head and Neck CancerCdData MappingMultiple SitesInductionIndexesEclInfluenzaPanRNAConstructionVectorSequencingClinical DevelopmentELISPOTScholarshipsSopsBiophysicsTriadTreatmentNeckOrganizational StructureJapanDetectionNihStrainsBiacoreSimianManagementDyesPeptidesScienceCellular CommunicationsResumeDisStatisticsExcellent Communication Skills in EnglishSensitivityHIVSopColorectalMouseCharlotteBurnettPaup*BostonPublicationsBloodScientific BackgroundEpidemiologyCollaborativeSequencherResHPLCQualificationCell Based Assays Ab Neutralization AssayAntibodiesIsolationEntryFoundationLanguagesCellWestern blotEnglishIncluding H1n1CeaLINDisease ControlVaccines Against Viruses Hiv and InfluenzaPublic HealthWalkerBeerFluorescenceLuminescenceMedicineHearingTestingProstate CancerDenverProgressionePubMagi AssayPeaceFACSRegulatory SubmissionsCell Based AssaysDiabetesConferencesKindsVirusNcbiJapanese and ChineseResearchDetection Technologies FluorescenceBladder CancerInvestigationAdenovirusCtl 51cr Release AssayAnalysisBindingWrittenPrintMolecularMechanismsAll Stages of Monoclonal Antibody GenerationSandersLettersHIV/AIDSTcrMultiple Projects SimultaneouslyRE1Nucleic AcidMcCladeSite Directed MutagenesisAnimalsExperimentationSportsVirusesCWestern BlottingKindImmunizationImmunogenicityData AnalysisChineseHbvClayAssay DevelopmentCommunicationWriting Nih Grants for PiDNAToxicityAdvertisingAnimal Models Mouse or Monkey Models or Human SamplesSafetyCharacterizationOperationsStagePostersWeightAuthorChristian MinistryComparativeBladderOpportunisticImmunityCtl Epitope MappingClinical Research and Clinical TrialsSakaiSAP XIBreast CancerBiochemistryDatabase DesignInfectious Diseases Hiv/AidsMechanismCtlFlow CytometryPresentationsJapaneseTherapistsTargeted AdvertisingCancer ResearchLabellingComparisonGenetic AnalysisBiologyE2bELISAProficient With Mega3.1Laboratory MedicinePaupCloneGrantsPreventionCmvWangLanlHumDocument GenerationSequenceSkilled in Flow CytometryConstruction of PlasmidCmiCell BasedSubjectsPharmaceuticsWelfareMttChinaStabilitySerumCd and BiacoreAntigenMhc Restriction TypingAntiviralClustalwCultureColonStaff DevelopmentImmunotherapyInfectionBroad ExperienceConceptual ModelingT CellsGenescanData TrackingEvaluationDevelopment of Analytical Methods for Assay Validation and TransferAll Stage of Ctl Clone GenerationCancer VaccinesCnacer VaccinesVaccines Against VirusesDetection Technologies

Younong Xu Contact Information

Work email●●●●●●●●@company.com

Personal email●●●●●●●●@gmail.com

Phone+● ●●● ●●● ●●●●

Unlock Younong's contact information

Start with a $2.99 7-day trial — verified email & phone in seconds.

Frequently Asked Questions about Younong Xu

How can I contact Younong Xu?

You can reach Younong Xu via verified work email, personal email, or phone number — all available after sign-in. We provide professional and personal contact channels along with social profiles.

Where does Younong Xu work?

Younong Xu currently works at XXX Biopharm Ltd. as Younong Xu - Chief Technology Officer at XXX Biopharm Ltd..

Where is Younong Xu located?

Younong Xu is based in WA.

Is the data on this page verified?

Yes — all profiles on WhiteBridge are sourced from publicly available data and continuously refreshed. Contact information is verified at the time of unlock.

Browse related